# TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)

> **NCT03783559** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 168 (actual)

## Conditions studied

- Colorectal Adenocarcinoma Metastatic to the Liver

## Interventions

- **DRUG:** TACE
- **DRUG:** chemotherapy±target therapy

## Key facts

- **NCT ID:** NCT03783559
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-12
- **Final completion:** 2021-03
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2019-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783559, "TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03783559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*